Trump praised ‘natural 7-OH’; DEA moves to ban it
Two months after President Donald Trump said his administration was looking “very seriously” at approving “natural 7-OH,” the Drug Enforcement Administration moved Wednesday to place the substance into Schedule I as a controlled opioid.
7-OH, or 7-hydroxymitragynine, is a psychoactive compound in the kratom plant, sold in gas stations and smoke shops as tablets, gummies and drink mixes.
The designation would subject anyone who makes, distributes or sells 7-OH above the threshold to the same federal criminal, civil and administrative penalties as heroin or LSD – enforcement DEA would carry out for up to two years under existing agency budget and staffing.
Trump made the comment May 11 in the Oval Office during a maternal health event, telling reporters, “We’re looking very seriously at natural 7-OH and getting that approved.”
The notice of intent DEA filed Wednesday would place 7-OH above a specified threshold into Schedule I, including botanical kratom material, not just synthetic products. The threshold covers kratom exceeding 0.050% 7-OH by dry weight, with no exception for natural products.
“7-OH, MP, MGM-15, and MGM-16 are dangerous opioids that fuel addiction and put American lives at risk,” HHS Secretary Robert F. Kennedy Jr. said in a statement. DEA Administrator Terrance Cole said the action targets “highly concentrated, synthetic 7-OH products.”
DEA filed two notices of intent with the Federal Register Wednesday; both publish July 6. HHS opened a public comment period on the threshold through July 31. DEA can issue a final temporary order 30 days after publication, effective for two years.
DEA cited 165 poison control exposure cases involving 7-OH from January through July 2025, with 35% resulting in serious health problems. Nine states have already banned 7-OH outright; four more cap its concentration.
The action follows FDA warning letters to seven companies selling 7-OH products in July 2025 and a December 2025 seizure of about $1 million worth of 7-OH products from three Missouri firms.
Latest News Stories
TrumpRx expanding, offering generic prescription drugs
Trump pauses planned military strikes against Iran, cites further negotiations
Consumer advocates say Nicor’s rate hike is unreasonable, profit-driven
Johnson’s office counters Pritzker claim Chicago mayor ‘has no plan’ to keep Bears
Pritzker: Trump war to blame for high gas prices
Proposed law would require women’s restroom on construction sites
Illinois Quick Hits: Independent candidate filing period opens
Pitching Duel Leads Casey-Westfield to Narrow 1-0 Shutout Over Danville
Casey-Westfield Offense Explodes in 16-1 Rout of Villa Grove
Illinois lawmaker calls for Aurora mayor’s resignation over alleged ICE ‘doxxing’
Fifth-Inning Rally Lifts Casey-Westfield Past Fairfield, 3-1
Spanberger vows to get Virginians ‘representation we deserve’